ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ASMB vs ALT // DIVIDEND YIELD & FCF PAYOUT SAFETY

Assembly Biosciences Inc. (NASDAQ) VS. Altimmune Inc. (NASDAQ) • 15-METRIC TALLY: ASMB 8 — ALT 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ASMB VS. ALT) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ASMB ALT SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -6.50% -34.70% +28.20 ASMB /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -9.69% -16.23% +6.54 ASMB /fcf-yield <GO>
Operating Margin -16.80% -60.00% +43.20 ASMB /operating-margins <GO>
Net Profit Margin -8.50% -60.00% +51.50 ASMB /net-margins <GO>
Revenue Growth (YoY) 153.50% 105.00% +48.50 ASMB /revenue-growth <GO>
Dividend Yield & FCF Payout Safety ACTIVE 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 1.57 1.30 +0.27 ASMB /balance-sheet <GO>
Piotroski F-Score Quality 3/9 5/9 -2.00 ALT /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 35.9 26.7 +9.19 ASMB /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $424.7M $416.3M $8.5M ASMB /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ASMB REV ALT REV ASMB GROSS % ALT GROSS % ASMB FCF ALT FCF
FY 2025 $72.3M $41.0K — — -$41.2M -$67.5M
FY 2024 $28.5M $20.0K — — -$51.1M -$79.8M
FY 2023 $0 $426.0K — — $22.7M -$75.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ASMB // BETA —
ALT // BETA —